Prime Medicine, Inc. Shareholders Equity (Other)

Shareholders Equity (Other) of PRME for past 10 years: annual, quarterly and twelve month trailing (TTM) including Shareholders Equity (Other) growth rates and interactive chart.


Highlights and Quick Summary

  • Shareholders Equity (Other) for the quarter ending June 30, 2022 was $0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Shareholders Equity (Other) decreased by NaN%
  • Annual Shareholders Equity (Other) for 2020 was $0
Visit stockrow.com/PRME for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Shareholders Equity (Other) of Prime Medicine, Inc.

Most recent Shareholders Equity (Other)of PRME including historical data for past 10 years.

Interactive Chart of Shareholders Equity (Other) of Prime Medicine, Inc.

Prime Medicine, Inc. Shareholders Equity (Other) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.0 $0.0
2021 $0.0
2020 $0.0 $0.0

Business Profile of Prime Medicine, Inc.

Sector: Healthcare
Industry: Biotechnology